• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 SYS PED.W/SA20 A.BURRHOLE RES; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 SYS PED.W/SA20 A.BURRHOLE RES; HYDROCEPHALUS VALVES Back to Search Results
Model Number FX448T
Device Problems Obstruction of Flow (2423); Blocked Connection (2888)
Patient Problem Failure of Implant (1924)
Event Date 11/12/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Patient information: unknown (height and gender).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional,"3y po valve is blocked.Explanted.".
 
Manufacturer Narrative
Manufacturing and quality control data: all parameters have been inspected and approved during the manufacturing process.All parameters have been assessed as meeting specifications.Investigation: visual inspection: scratches on the outer housing of the valves were observed through the visual inspection.No significant deformations or damages were detected.Permeability test: a permeability test has shown that both valves are permeable adjustment test: the progav 2.0 valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Computer controlled test: to test the opening pressure, we use a miethke computer controlled testing apparatus, which simulates a cerebrospinal fluid flow.The tests have shown that both valves are operating within acceptable tolerances.Results: we have dismantled the valve.Inside both valves we have found significant build up of substances (likely protein).Based on our investigation, we are unable to substantiate the claim of occlusion or of underdrainage.The valves operate within the specified tolerances.However it is possible that the deposits observed inside the valves could have temporarily caused the malfunction if the past.As described in our literature, the problem encountered is one of the known inevitable risks of hc-therapy by shunt implants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 SYS PED.W/SA20 A.BURRHOLE RES
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8152947
MDR Text Key129980899
Report Number3004721439-2018-00292
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 12/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/11/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Model NumberFX448T
Device Catalogue NumberFX448T
Device Lot Number20027305
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/16/2018
Distributor Facility Aware Date12/11/2018
Device Age3 YR
Date Manufacturer Received12/11/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age3 YR
Patient Weight11
-
-